Showing 2661-2670 of 4166 results for "".
- Bausch + Lomb Publishes Teneo Excimer Laser Clinical Trial Resultshttps://modernod.com/news/bausch-lomb-publishes-teneo-excimer-laser-clinical-trial-results/2482393/Bausch + Lomb announced the publication of clinical trial results for its Teneo Excimer Laser in the August issue of the Journal of Refractive Surgery. These findings supported the FDA approval of the Teneo platform for LASIK in January 2024, specifically for myopia and myopic astig
- Aurion Biotech Announces Completion of Enrollment in Phase 1/2 Clinical Trialhttps://modernod.com/news/aurion-biotech-announces-completion-of-enrollment-in-phase-12-clinical-trial/2482253/Aurion Biotech announced it has completed dosing of all subjects in its phase 1/2 clinical trial (CLARA) of AURN001, an allogeneic cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction. AURN001 is a combination cell therapy product (biologic/d
- Oculis Provides Updates on Late-Stage Clinical Trials; Announces Leadership Appointmentshttps://modernod.com/news/oculis-provides-updates-on-late-stage-clinical-trials-announces-leadership-appointments/2482135/Oculis provided updates its late-stage clinical trials, and also announced senior appointments to its management and advisory teams. The announcements were made during it R&D Day on Wednesday, February 28. “2024 promises to be another exciting year for Ocu
- iuvo BioScience Acquires Promedica International to Expand Ophthalmic Clinical CRO Serviceshttps://modernod.com/news/iuvo-bioscience-acquires-promedica-international-to-expand-ophthalmic-clinical-cro-services/2482070/Partner Research Organization iuvo BioScience announced it has acquired Promedica International (PMI), an ophthalmology-focused clinical CRO. Financial terms of the deal were not disclosed. The companies say the combined organization will support all aspects of opht
- Okogen Initiates Phase 2b Clinical Trial for Acute Infectious Conjunctivitishttps://modernod.com/news/okogen-initiates-phase-2b-clinical-trial-for-acute-infectious-conjunctivitis/2481926/Okogen announced the initiation of a phase 2b clinical trial evaluating OKG-0303 for acute infectious conjunctivitis (pink eye) to be conducted in India. Additionally, as part of the corporate reorganization, Bradford Conlan has been appointed Executive Chairman; and Joshua Moriarty, Okogen&
- Genentech Presents Post-Hoc Clinical and Real-World Data for Vabysmo at ASRShttps://modernod.com/news/genentech-presents-post-hoc-clinical-and-real-world-data-for-vabysmo-at-asrs/2481737/Genentech announced that data from its ophthalmology portfolio will be highlighted in 25 abstracts at the 2023 American Society of Retina Specialists (ASRS) annual meeting, which will be held from July 28-August 1 in Seattle. The data advance the clinical and real-world evidence supporting t
- ViaLase to Present Clinical Data at the 2023 ASCRS Annual Meetinghttps://modernod.com/news/vialase-to-present-clinical-data-at-the-2023-ascrs-annual-meeting/2481582/ViaLase announced that it will present first-in-human clinical data and a technology overview during the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting to be held May 5-8, 2023 in San Diego, California. Presentati
- BVI Completes Enrollment of Finevision HP IDE Clinical Studyhttps://modernod.com/news/bvi-completes-enrollment-of-finevision-hp-ide-clinical-study/2481581/BVI announced it has completed enrollment of its US Investigational Device Exemption (IDE) clinical study for its latest hydrophobic trifocal IOL, Finevision HP. The milestone marks the final implantation of the 539th patient enrolled in the prospective, multicenter, rand
- Precision Eye Therapy for Dogs Ready for Human Clinical Developmenthttps://modernod.com/news/precision-eye-therapy-for-dogs-ready-for-human-clinical-development/2481576/A successful gene therapy trialed at Michigan State University in dogs with an inherited eye disease is ready to be developed for clinical use in human patients with retinitis pigmentosa, according to a university news release. Simon Petersen-Jones, professor and Donald R. Myers and Wil
- Keranova Announces Clinical Study Results for Robotic Laser Technologyhttps://modernod.com/news/keranova-announces-clinical-study-results-for-robotic-laser-technology/2481345/Keranova announced the finalization of the regulatory clinical studies of FemtoMatrix, its robotic laser technology. With the positive results, the company said it will now apply for CE marking for this new class of surgical equipment in cataract surgery. According to Ker